Works matching IS 08876924 AND DT 2009 AND VI 23 AND IP 10

Results: 31

Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1836, doi. 10.1038/leu.2009.100

By:

Gelebart, P.;
Zak, Z.;
Anand, M.;
Dien-Bard, J.;
Amin, H. M.;
Lai, R.

Publication type:

Article

Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.

Published in:

2009

By:

Carter, B. Z.;
Mak, D. H.;
Woessner, R.;
Gross, S.;
Schober, W. D.;
Estrov, Z.;
Kantarjian, H.;
Andreeff, M.

Publication type:

journal article

Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1763, doi. 10.1038/leu.2009.102

By:

Cho, B.-S.;
Lee, S.;
Kim, Y.-J.;
Chung, N.-G.;
Eom, K.-S.;
Kim, H.-J.;
Min, C.-K.;
Cho, S.-G.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.;
Kim, C.-C.

Publication type:

Article

STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1885, doi. 10.1038/leu.2009.103

By:

Baus, D.;
Nonnenmacher, F.;
Jankowski, S.;
Döring, C.;
Bräutigam, C;
Frank, M.;
Hansmann, M.-L.;
Pfitzner, E.

Publication type:

Article

Erythroid/B-cell biphenotypic acute leukemia first case report.

Published in:

2009

By:

Lee, J. C.;
Yang, S.;
Zou, Y.;
Joseph, L.

Publication type:

Letter

Interferon-gamma-induced neuronal differentiation of human umbilical cord blood-derived progenitors.

Published in:

2009

By:

Arien-Zakay, H.;
Lecht, S.;
Bercu, M. M.;
Amariglio, N.;
Rechavi, G.;
Galski, H.;
Lazarovici, P.;
Nagler, A.

Publication type:

journal article

Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1801, doi. 10.1038/leu.2009.107

By:

Cheng, Y.;
Wang, Y.;
Wang, H.;
Chen, Z.;
Lou, J.;
Xu, H.;
Wand1,2, H.;
Qian, W.;
Meng, H.;
Lin, M.;
Jin, J.

Publication type:

Article

Identification of MNDA as a new marker for nodal marginal zone lymphoma.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1847, doi. 10.1038/leu.2009.108

By:

Kanellis, G.;
Roncador, G.;
Arribas, A.;
Mollejo, M.;
Montes-Moreno, S.;
Maestre, L.;
Campos-Martin, Y.;
Ríos Gonzalez, J. L.;
Martinez-Torrecuadrada, J. L.;
Sanchez-Verde, L.;
Pajares, R.;
Cigudosa, J. C.;
Martin, M. C.;
Piris, M. A.

Publication type:

Article

Stem-cell collection before high-dose therapy for multiple myeloma: time has come to raise the standards!

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1689, doi. 10.1038/leu.2009.109

By:

Mohty, M.

Publication type:

Article

The ‘GGCC’ haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1924, doi. 10.1038/leu.2009.110

By:

Olcaydu, D.;
Skoda, R. C.;
Looser, R.;
Li, S.;
Cazzola, M.;
Pietra, D.;
Passamonti, F.;
Lippert, E.;
Carillo, S.;
Girodon, F.;
Vannucchi, A.;
Reading, N. S.;
Prchal, J. T.;
Ay, C.;
Pabinger, I.;
Gisslinger, H.;
Kralovics, R.

Publication type:

Article

Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1698, doi. 10.1038/leu.2009.111

By:

Giles, F. J.;
O'Dwyer, M.;
Swords, R.

Publication type:

Article

Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1708, doi. 10.1038/leu.2009.142

By:

Goldman, J. M.;
Green, A. R.;
Holyoake, T.;
Jamieson, C.;
Mesa, R.;
Mughal, T.;
Pellicano, F.;
Perrotti, D.;
Skoda, R.;
Vannucchi, A. M.

Publication type:

Article

MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM.

Published in:

2009

By:

Rambal, A. A.;
Panaguiton, Z. L. G.;
Kramer, L.;
Grant, S.;
Harada, H.

Publication type:

journal article

The 1170 A–P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag).

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1926, doi. 10.1038/leu.2009.112

By:

Wenandy, L.;
Kollgaard, T.;
Letsch, A.;
Andersen, R. S.;
Stather, D.;
Seremet, T.;
Svane, I. M.;
Vindeløv, L.;
Andersen, M. H.;
Straten, P. thor

Publication type:

Article

Heritable T-cell malignancy models established in a zebrafish phenotypic screen.

Published in:

2009

By:

Frazer, J. K.;
Meeker, N. D.;
Rudner, L.;
Bradley, D. F.;
Smith, A. C. H.;
Demarest, B.;
Joshi, D.;
Locke, E. E.;
Hutchinson, S. A.;
Tripp, S.;
Perkins, S. L.;
Trede, N. S.

Publication type:

journal article

Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma.

Published in:

2009

By:

Gasperini, P.;
Tosato, G.

Publication type:

journal article

Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1818, doi. 10.1038/leu.2009.138

By:

Schmidt, S. M.;
König, T.;
Bringmann, A.;
Held, S.;
von Schwarzenberg, K.;
Heine, A.;
Holderried, T. A. W.;
Stevanovic, S.;
Grünebach, F.;
Brossart, P.

Publication type:

Article

SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1929, doi. 10.1038/leu.2009.113

By:

Mahlknecht, U.;
Dransfeld, C.-L.;
Bulut, N.;
Kramer, M.;
Thiede, C.;
Ehninger, G.;
Schaich, M.

Publication type:

Article

Array-based DNA methylation profiling in follicular lymphoma.

Published in:

2009

By:

O'Riain, C.;
O'Shea, D. M.;
Yang, Y.;
Le Dieu, R.;
Gribben, J. G.;
Summers, K.;
Yeboah-Afari, J.;
Bhaw-Rosun, L.;
Fleischmann, C.;
Mein, C. A.;
Crook, T.;
Smith, P.;
Kelly, G.;
Rosenwald, A.;
Ott, G.;
Campo, E.;
Rimsza, L. M.;
Smeland, E. B.;
Chan, W. C.;
Johnson, N.

Publication type:

journal article

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1731, doi. 10.1038/leu.2009.124

By:

Falini, B.;
Bolli, N.;
Liso, A.;
Martelli, M. P.;
Mannucci, R.;
Pileri, S.;
Nicoletti, I.

Publication type:

Article

Src family kinase gene targets during myeloid differentiation: identification of the EGR-1 gene as a direct target.

Published in:

2009

By:

Jones, J. E.;
Wang, L.;
Kropf, P. L.;
Duan, R.;
Johnson, D. E.

Publication type:

Letter

Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia.

Published in:

2009

By:

Castro, J. E.;
James, D. F.;
Sandoval-Sus, J. D.;
Jain, S.;
Bole, J.;
Rassenti, L.;
Kipps, T. J.

Publication type:

journal article

Vorinostat interferes with Wnt and NF-κB pathways in the M-07e cell line.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1935, doi. 10.1038/leu.2009.119

By:

Galimberti, S.;
Canestraro, M.;
Maffei, R.;
Marasca, R.;
Guerrini, F.;
Piaggi, S.;
Ciabatti, E.;
Petrini, M.

Publication type:

Article

Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1875, doi. 10.1038/leu.2009.120

By:

Schwindt, H.;
Vater, I.;
Kreuz, M.;
Montesinos-Rongen, M.;
Brunn, A.;
Richter, J.;
Gesk, S.;
Ammerpohl, O.;
Wiestler, O. D.;
Hasenclever, D.;
Deckert, M.;
Siebert, R.

Publication type:

Article

The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models.

Published in:

2009

By:

Deleu, S.;
Lemaire, M.;
Arts, J.;
Menu, E.;
Van Valckenborgh, E.;
King, P.;
Broek, I. Vande;
De Raeve, H.;
Van Camp, B.;
Croucher, P.;
Vanderkerken, K.;
Vande Broek, I

Publication type:

journal article

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1716, doi. 10.1038/leu.2009.122

By:

Palumbo, A.;
Sezer, O.;
Kyle, R.;
Miguel, J. S.;
Orlowski, R. Z.;
Moreau, P.;
Niesvizky, R.;
Morgan, G.;
Comenzo, R.;
Sonneveld, P.;
Kumar, S.;
Hajek, R.;
Giralt, S.;
Bringhen, S.;
Anderson, K. C.;
Richardson, P. G.;
Cavo, M.;
Davies, F.;
Bladé, J.;
Einsele, H.

Publication type:

Article

Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1691, doi. 10.1038/leu.2009.134

By:

Landgren, O.;
Weiss, B. M.

Publication type:

Article

SDF-1 and PDGF enhance αvβ5-mediated ERK activation and adhesion-independent growth of human pre-B cell lines.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1807, doi. 10.1038/leu.2009.126

By:

Acharya, M.;
Edkins, A. L.;
Ozanne, B. W.;
Cushley, W.

Publication type:

Article

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

Published in:

2009

By:

Giralt, S.;
Stadtmauer, E. A.;
Harousseau, J. L.;
Palumbo, A.;
Bensinger, W.;
Comenzo, R. L.;
Kumar, S.;
Munshi, N. C.;
Dispenzieri, A.;
Kyle, R.;
Merlini, G.;
Miguel, J. San;
Ludwig, H.;
Hajek, R.;
Jagannath, S.;
Blade, J.;
Lonial, S.;
Dimopoulos, M. A.;
Einsele, H.;
Barlogie, B.

Publication type:

journal article

Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.

Published in:

2009

By:

Durie, B. G. M.;
Van Ness, B.;
Ramos, C.;
Stephens, O.;
Haznadar, M.;
Hoering, A.;
Haessler, J.;
Katz, M. S.;
Mundy, G. R.;
Kyle, R. A.;
Morgan, G. J.;
Crowley, J.;
Barlogie, B.;
Shaughnessy, Jr., J.;
Shaughnessy, J Jr

Publication type:

journal article

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1771, doi. 10.1038/leu.2009.98

By:

Giannopoulos, K.;
Dmoszynska, A.;
Kowal, M.;
Wąsik-Szczepanek, E.;
Bojarska-Junak, A.;
Rolinski, J.;
Döhner, H.;
Stilgenbauer, S.;
Bullinger, L.

Publication type:

Article